Showing interest in a new way that brand-name drug companies and makers of competing generic versions of their drugs can divide up markets, the Supreme Court on Monday asked for the advice of the federal government on whether that kind of arrangement runs afoul of antitrust law.  One independent part of the government, the Federal Trade Commission, already holds … Continue reading Court seeks advice on new generic drug deal